Literature DB >> 19274341

Pharmacological effects and behavioral interventions on memory consolidation and reconsolidation.

C M Baratti1, M M Boccia, M G Blake.   

Abstract

In this article, we will review some behavioral, pharmacological and neurochemical studies from our laboratory on mice, which might contribute to our understanding of the complex processes of memory consolidation and reconsolidation. We discuss the post-training (memory consolidation) and post-reactivation (memory reconsolidation) effects of icv infusions of hemicholinium, a central inhibitor of acetylcholine synthesis, of intraperitoneal administration of L-NAME, a non-specific inhibitor of nitric oxide synthase, of intrahippocampal injections of an inhibitor of the transcription factor NF-kappaB, and the exposure of mice to a new learning situation on retention performance of an inhibitory avoidance response. All treatments impair long-term memory consolidation and retrieval-induced memory processes different from extinction, probably in accordance with the 'reconsolidation hypothesis'.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19274341     DOI: 10.1590/s0100-879x2009000200001

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  3 in total

Review 1.  Nitric Oxide: Exploring the Contextual Link with Alzheimer's Disease.

Authors:  Nicholas Asiimwe; Seung Geun Yeo; Min-Sik Kim; Junyang Jung; Na Young Jeong
Journal:  Oxid Med Cell Longev       Date:  2016-12-21       Impact factor: 6.543

2.  Activation of NF-κB in basolateral amygdala is required for memory reconsolidation in auditory fear conditioning.

Authors:  Jijian Si; Jianli Yang; Lifen Xue; Chenhao Yang; Yixiao Luo; Haishui Shi; Lin Lu
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

Review 3.  Relevance of ERK1/2 Post-retrieval Participation on Memory Processes: Insights in Their Particular Role on Reconsolidation and Persistence of Memories.

Authors:  Maria C Krawczyk; Julieta Millan; Mariano G Blake; Mariana Feld; Mariano M Boccia
Journal:  Front Mol Neurosci       Date:  2019-04-17       Impact factor: 5.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.